Board Stats

Inovio Biomedical Corporation

TECH UPDATE, Sunday, 9/26/2021, 12 p.m. EDT

While it took longer than projected, knock on wood, yesterday's maintenance work appears to have been a success. Most of the heavy lifting has been done, including upgrading several hard drives and back end switches to improve overall system storage, security and connectivity. Work will continue on a moderated basis over the next several weeks to ensure a smooth transition. Our primary infrastructure technician will continue to monitor and tweak the upgraded equipment until things settle into a stable, manageable routine. If we hit any snags along the way (which unfortunately I can't rule out) please accept our apologies in advance. The goal, of course, is to improve user experience for all our customers and that's what we remain focused on and committed to delivering. Thanks in advance for your continued patience, understanding & support.

Y! Inovio company website #INO @ Stocktwits $INO stream @ Twitter @InovioPharma (Company Twitter Account) INO Facebook Page INO YouTube Channel INO @ LinkedIn

INO / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
2139	Could help Revenue	GN	billmax		2	9/22/2021 9:20:45 AM

2138	Inovio: COVID-19 value likely to continue to decline; Moving to U/P from Neutral	GN	billmax		0	9/10/2021 9:16:23 AM

2137	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	no_gluts_no_gory		1	9/1/2021 9:20:27 PM

2136	INOVIO to Present at Upcoming Investor Conferences in September	GN	billmax		1	9/1/2021 8:28:48 AM

2135	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	co3aii		0	8/28/2021 1:04:45 PM

2134	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	billmax		0	8/28/2021 11:06:04 AM

2133	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	co3aii		1	8/28/2021 10:17:26 AM

2132	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	billmax		0	8/27/2021 3:52:36 PM

2131	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	co3aii		0	8/27/2021 2:46:46 PM

2130	Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800	GN	billmax		0	8/27/2021 1:10:35 PM

BOARDS Sign In for Filters